Nate Milburn, MD
Internal Medicine · Dallas, TXNPI 1558802868
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,100 of the $7,188 with a category attached, or 71.0%. Trice Medical, Inc. accounts for 95.1% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $5,599, more than ten times the $34 reported in 2022. Among internal medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $287.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trice Medical, Inc.$7K
- Ferring Pharmaceuticals Inc.$181
- Bioventus LLC$154
- Merck$17
What the payments were for
- Consulting fees$5,10071%
- Travel & lodging$1,08615%
- Food & beverage$1,00214%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trice Medical, Inc. | 12 | $6,836 |
| Ferring Pharmaceuticals Inc. | 8 | $181 |
| Bioventus LLC | 4 | $154 |
| Merck | 1 | $17 |
How this compares
$7,188 in reported general payments places this provider in the 90th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 115 | $1,134 |
| Celecoxib | 11 | $215 |
| Methylprednisolone | 23 | $147 |
| Meloxicam | 16 | $131 |
| Prednisone | 16 | $38 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Dallas
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Han SchmidlyDallas$465K
- Athica VatanapradithDallas$164K
- Nicholaos BellosDallas$113K
- Steven HeldDallas$65K
- Amit VermaDallas$53K
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Mohammed Al-NajjarEl Paso$586K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.